Advanced Malignant Tumors clinical trials

Explore recruiting advanced malignant tumors clinical trials.

Recruiting advanced malignant tumors studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Malignant Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Study of Relatlimab (anti-LAG-3 Monoclonal Antibody) Administered in Combination with Both Nivolumab (anti-PD-1 Monoclonal Antibody) and BMS-986205 (IDO1 inhibitor) or in Combination with Both Nivolumab and Ipilimumab (anti-CTLA-4 Monoclonal Antibody) in Advanced Malignant Tumors

Italy, France, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1 Study of BMS-986406 as Monotherapy and in Combination in Advanced Tumors

Spain, Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination with Nivolumab in Advanced Malignant Tumors

Spain, France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase I/II, open-label, adaptive two-part trial to evaluate the safety, efficacy, optimal dose and pharmacokinetics of BNT326 as monotherapy and in combination with cancer immunotherapies in participants with advanced solid tumors

Belgium, Germany, Spain, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Malignant Tumors trials by city

Advanced Malignant Tumors clinical trials

Recruiting advanced malignant tumors studies right now

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

A Clinical Study of MIL95 in Advanced Malignancies.

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration

Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma